Literature DB >> 33833034

Integrating haemodynamics identifies an extreme pulmonary hypertension phenotype.

William M Oldham1, Edward Hess2, Stephen W Waldo2, Marc Humbert3, Gaurav Choudhary4, Bradley A Maron5,6.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33833034      PMCID： PMC8529828          DOI： 10.1183/13993003.04625-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   33.795


× No keyword cloud information.
  10 in total

1.  Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

Authors:  Marius M Hoeper; Tilmann Kramer; Zixuan Pan; Christina A Eichstaedt; Jens Spiesshoefer; Nicola Benjamin; Karen M Olsson; Katrin Meyer; Carmine Dario Vizza; Anton Vonk-Noordegraaf; Oliver Distler; Christian Opitz; J Simon R Gibbs; Marion Delcroix; H Ardeschir Ghofrani; Doerte Huscher; David Pittrow; Stephan Rosenkranz; Ekkehard Grünig
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.

Authors:  Paul W Armstrong; Carolyn S P Lam; Kevin J Anstrom; Justin Ezekowitz; Adrian F Hernandez; Christopher M O'Connor; Burkert Pieske; Piotr Ponikowski; Sanjiv J Shah; Scott D Solomon; Adriaan A Voors; Lilin She; Vanja Vlajnic; Francine Carvalho; Luke Bamber; Robert O Blaustein; Lothar Roessig; Javed Butler
Journal:  JAMA       Date:  2020-10-20       Impact factor: 56.272

Review 3.  Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review.

Authors:  G Kovacs; A Berghold; S Scheidl; H Olschewski
Journal:  Eur Respir J       Date:  2009-03-26       Impact factor: 16.671

Review 4.  Evaluation and management of pulmonary arterial hypertension.

Authors:  Sarah Beshay; Sandeep Sahay; Marc Humbert
Journal:  Respir Med       Date:  2020-08-19       Impact factor: 3.415

5.  Network Analysis to Risk Stratify Patients With Exercise Intolerance.

Authors:  William M Oldham; Rudolf K F Oliveira; Rui-Sheng Wang; Alexander R Opotowsky; David M Rubins; Jon Hainer; Bradley M Wertheim; George A Alba; Gaurav Choudhary; Adrienn Tornyos; Calum A MacRae; Joseph Loscalzo; Jane A Leopold; Aaron B Waxman; Horst Olschewski; Gabor Kovacs; David M Systrom; Bradley A Maron
Journal:  Circ Res       Date:  2018-02-05       Impact factor: 17.367

6.  Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University.

Authors:  Alexander R Opotowsky; Edward Hess; Bradley A Maron; Evan L Brittain; Anna E Barón; Thomas M Maddox; Laith I Alshawabkeh; Bradley M Wertheim; Meng Xu; Tufik R Assad; Jonathan D Rich; Gaurav Choudhary; Ryan J Tedford
Journal:  JAMA Cardiol       Date:  2017-10-01       Impact factor: 14.676

7.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Authors:  Bradley A Maron; Edward Hess; Thomas M Maddox; Alexander R Opotowsky; Ryan J Tedford; Tim Lahm; Karen E Joynt; Daniel J Kass; Thomas Stephens; Maggie A Stanislawski; Erik R Swenson; Ronald H Goldstein; Jane A Leopold; Roham T Zamanian; Jean M Elwing; Mary E Plomondon; Gary K Grunwald; Anna E Barón; John S Rumsfeld; Gaurav Choudhary
Journal:  Circulation       Date:  2016-02-12       Impact factor: 29.690

8.  Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow?

Authors:  Lauren B Cooper; Robert J Mentz; Susanna R Stevens; G Michael Felker; Carlo Lombardi; Marco Metra; Lynne W Stevenson; Christopher M O'Connor; Carmelo A Milano; Chetan B Patel; Joseph G Rogers
Journal:  J Card Fail       Date:  2015-12-15       Impact factor: 5.712

9.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; David Montani; David S Celermajer; Christopher P Denton; Michael A Gatzoulis; Michael Krowka; Paul G Williams; Rogerio Souza
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

10.  Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study.

Authors:  Bradley A Maron; Evan L Brittain; Edward Hess; Stephen W Waldo; Anna E Barón; Shi Huang; Ronald H Goldstein; Tufik Assad; Bradley M Wertheim; George A Alba; Jane A Leopold; Horst Olschewski; Nazzareno Galiè; Gerald Simonneau; Gabor Kovacs; Ryan J Tedford; Marc Humbert; Gaurav Choudhary
Journal:  Lancet Respir Med       Date:  2020-07-27       Impact factor: 30.700
  10 in total
  2 in total

Review 1.  Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension.

Authors:  Christopher J Rhodes; Andrew J Sweatt; Bradley A Maron
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

2.  Tadalafil for veterans with chronic obstructive pulmonary disease-pulmonary hypertension: A multicenter, placebo-controlled randomized trial.

Authors:  Bradley A Maron; Gaurav Choudhary; Rebekah L Goldstein; Eric Garshick; Matthew Jankowich; Troo J S Tucker; Kathleen A LaCerda; Brack Hattler; Edward C Dempsey; Ruxana T Sadikot; Shelley Shapiro; Sharon I Rounds; Ronald H Goldstein
Journal:  Pulm Circ       Date:  2022-03-14       Impact factor: 2.886
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.